generics

Amneal to buy generic pharmaceuticals provider AvKARE for $340m
Amneal to buy generic pharmaceuticals provider AvKARE for $340m
Pharmaceutical Business Review
Amneal
generics
M&A
AvKARE
Flag link:
Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry?
Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry?
FDA Law Blog
FDA
drug pricing
Hatch Waxman Act
legislation
regulatory
generics
Flag link:
Prescription Drug Prices Dip Slightly in the U.S., the First Time in 45 Years
Prescription Drug Prices Dip Slightly in the U.S., the First Time in 45 Years
BioSpace
drug pricing
generics
Flag link:
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Novartis
FDA
Gilenya
MS
multiple sclerosis
Mylan
Dr Reddy's
Torrent Pharmaceuticals
Aurobindo
generics
Flag link:
After Zantac scare, FDA targets generic metformin for carcinogen tests
After Zantac scare, FDA targets generic metformin for carcinogen tests
Fierce Pharma
generics
FDA
type 2 diabetes
metformin
Flag link:
DOJ inks price fixing settlement with small generics player. Will others follow?
DOJ inks price fixing settlement with small generics player. Will others follow?
Fierce Pharma
generics
price fixing
Rising Pharmaceuticals
DOJ
Flag link:
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Pharmaforum
Hikma
FDA
generics
GSK
Advair
asthma
COPD
Flag link:
Teva, others talk settlements with feds in yearslong generics price fixing probe: report
Teva, others talk settlements with feds in yearslong generics price fixing probe: report
Fierce Pharma
Teva Pharmaceutical
generics
price fixing
Taro Pharmaceuticals
Flag link:
FDA releases 81 product-specific guidances
FDA releases 81 product-specific guidances
Endpoints
FDA
generics
Flag link:
Despite Record Number of Generic Drug Approvals, Many Are Not Yet Available in the U.S.
Despite Record Number of Generic Drug Approvals, Many Are Not Yet Available in the U.S.
BioSpace
generics
Flag link:
Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?
Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?
Fierce Pharma
Mylan
Pfizer
Upjohn
M&A
generics
Viatris
Flag link:
What has Zantac recall cost drugmakers? Dr. Reddy's gives a hint
What has Zantac recall cost drugmakers? Dr. Reddy's gives a hint
Fierce Pharma
Zantac
OTC
product recalls
generics
Dr Reddy's
Flag link:
Novartis' Generics Unit to Buy Aspen's Japanese Operations
Novartis' Generics Unit to Buy Aspen's Japanese Operations
Yahoo/Zacks.com
Novartis
generics
Sandoz
M&A
Japan
Aspen Pharmacare
Aspen Global
Flag link:
Think Mylan's done with M&A after its Pfizer deal? Think again
Think Mylan's done with M&A after its Pfizer deal? Think again
Fierce Pharma
Mylan
Pfizer
M&A
Upjohn
generics
Flag link:
Under copycat attack, Amgen punches back with its own biosimilars
Under copycat attack, Amgen punches back with its own biosimilars
Fierce Pharma
Amgen
biosimilars
generics
Sensipar
Neulasta
Neupogen
Flag link:
FDA generic approvals hit a new record, but the effort's not paying off yet
FDA generic approvals hit a new record, but the effort's not paying off yet
Fierce Pharma
FDA
generics
drug approvals
Flag link:
Another Record Year for Generic Drug Approvals but Questions on Competition Remain
Another Record Year for Generic Drug Approvals but Questions on Competition Remain
RAPS.org
FDA
generics
drug approvals
generic approvals
Flag link:
Have FDA’s Generic Approvals Helped With Competition? Researchers Say Too Early to Tell
Have FDA’s Generic Approvals Helped With Competition? Researchers Say Too Early to Tell
RAPS.org
FDA
generics
competition
drug approvals
Flag link:
The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease?
The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease?
Stat
Vioxx
hemophilia
generics
Tremeau Pharmaceuticals
hemophilic arthropathy
Flag link:
Gilead scores PrEP approval for Descovy — kicking off marketing push before Truvada generics swarm
Gilead scores PrEP approval for Descovy — kicking off marketing push before Truvada generics swarm
Endpoints
Gilead Sciences
Descovy
HIV
PrEP
FDA
Truvada
generics
Flag link:

Pages